Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

myRocky vs RestorLife Med

myRocky
Graded #487

Lower grade

vs+11.800000000000004
RestorLife Med
Graded #261

Higher grade

The verdict

RestorLife Med takes it — 63.2/100 to 51.4/100.

RestorLife Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RestorLife Med is a physician-guided GLP-1 telehealth practice (founder Dr.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuemyRocky +8
34
26
Dose & formulationRestorLife Med +11
53
64
Clinical oversightRestorLife Med +33
64
97
Labs & monitoringRestorLife Med +14
52
66
FulfillmentRestorLife Med +27
70
97
Contract termsmyRocky +4
41
37
myRocky · left barRestorLife Med · right bar

The numbers

MetricmyRockyRestorLife Med
WeighScore51.4/10063.2/100
GradeCC
Scorecard rank#487#261
SemaglutideNot disclosed$299/mo (microdose tier, compounded)
TirzepatideNot disclosed$399/mo (microdose tier, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
myRocky

Graded #487 · C

Strengths

  • Brand-name FDA-approved GLP-1s (Ozempic, Mounjaro, Wegovy) on one platform — no compounded-product risk
  • LegitScript Approved
  • 42-state coverage with an 8-state expansion roadmap published
  • Multi-product platform for patients managing GLP-1 plus sexual health, hair loss, or mental health on one subscription

Where it loses points

  • Expensive stacked fees: $99 consult + $99/mo program fee + ~$1,409/mo medication = ~$1,508/mo
  • Canadian incorporation (Rocky Health Inc., Mississauga, ON) — verify your state's prescriber holds an active US license
  • Listed pharmacy is a Canadian community pharmacy; US-fulfillment supply chain not transparent
  • Brand-only — no compounded option for cost-sensitive patients
  • $1,409/mo Ozempic is near retail; compare NovoCare ($349/mo Wegovy pen) or LillyDirect ($449–$699/mo Zepbound)
RestorLife Med

Graded #261 · C

Strengths

  • Verifiable LegitScript certification (seal ID 50400451) plus a named board-certified physician (Dr. Michael Wasef, MD) licensed in all 50 states
  • Full GLP-1 lineup: compounded semaglutide and tirzepatide, plus gentler microdose entry options
  • Generous support — unlimited care-team messaging, monthly check-ins, dosage adjustments, and 1 free blood test per quarter on the GLP-1 protocols
  • Available in all 50 states with free priority shipping, discreet packaging, and roughly 48-hour delivery
  • Transparent multi-month pricing with 50% off your first month; semaglutide protocols are compounded with B12

Where it loses points

  • Compounded medications are not FDA-approved as finished products (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Ongoing pricing is mid-range ($299/mo semaglutide, $399/mo tirzepatide) after the discounted first month
  • The specific partner compounding pharmacy is not named
  • Also markets hormone therapy and anti-aging peptides, not GLP-1 exclusively

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard